Abstract
PURPOSE: Synopsis about the curative possibilities of an aggressive multimodal therapeutic approach for peritoneal metastases using positive prognostic selection criteria. PATIENTS AND METHODS: Published data concerning cytoreductive surgery in combination with intraoperative intraperitoneal hyperthermic chemotherapy and/or early postoperative intraperitoneal chemotherapy ± systemic chemotherapy in patients suffering from peritoneal carcinomatosis were analyzed with regard to subgroups with long-term survivors. RESULTS: Extent of peritoneal carcinomatosis and completeness of cytoreductive surgery are the most important prognostic factors predicting long-term survival. Histological differentiation, lymph node status, performance status, extent of prior therapy and age are further independent factors influencing the outcome. CONCLUSION: Strictly selecting patients with multiple positive prognostic factors might result in 5-year survival rates of 50% and more.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
